Abstract
AimTo confirm the hypothesis that the cytotoxicity of tanshinone IIA (TSA) is dependent on NAD(P)H quinone oxidoreductase (NQO1)-mediated biotransformation. MethodsMTT assay in a series of cell lines with diverse NQO1 enzyme activity in the presence or absence of the typical NQO1 inhibitor dicoumarol (DIC) was applied to test the NQO1-dependent cytotoxicity of TSA. Then the NQO1-dependent biotransformation of TSA in HepG2 cells was investigated with or without DIC. ResultsTSA's cytotoxicity is positively correlated with NQO1 enzyme activity in the cell lines. DIC could reverse the cytotoxicity of TSA in HepG2 cells with the highest NQO1 enzyme. DIC could also inhibit the biotransformation of TSA in HepG2 cells. ConclusionBy inhibiting NQO1, DIC could inhibit the biotransformation of TSA into a catechol intermediate in HepG2 cells, resulting in disturbance of the redox cycle of TSA, thereby reducing the cytotoxicity of TSA. In summary, NQO1-mediated biotransformation determines the cytotoxicity of Tanshinone IIA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
